Nantahala Capital Management, LLC - 31 Dec 2024 SCHEDULE 13G Report for INHIBIKASE THERAPEUTICS, INC. Common Stock, $0.001 par value (IKT)

Filing Manager
Nantahala Capital Management, LLC
Reporting Manager
Nantahala Capital Management, LLC
Security
INHIBIKASE THERAPEUTICS, INC. Common Stock, $0.001 par value
Symbol
IKT
Shares outstanding
70.3M shares
Disclosed Ownership
5.3M shares
Ownership
7.54%
Form type
SCHEDULE 13G
Filing time
14 Feb 2025, 16:32:39 UTC
Date of event
31 Dec 2024
SEC
View on sec.gov

Reporting Managers (3)

Name Ownership Shares Owned sole voting power shared voting power Signature Title CIK
Nantahala Capital Management, LLC 7.54% 5.3M 0 5.3M /s/ Taki Vasilakis Taki Vasilakis / Chief Compliance Officer
Wilmot B. Harkey 7.54% 5.3M 0 5.3M /s/ Wilmot B. Harkey Wilmot B. Harkey
Daniel Mack 7.54% 5.3M 0 5.3M /s/ Daniel Mack Daniel Mack